Dannuo Pharma 06872Stock Information

Stock Information
// Company Overview //
Stock NameDannuo Pharma
Stock Code06872
Company Full NameDannuo Pharma
Industry生物医药
Principal Activities專注於發現、開發及商業化差異化的創新藥產品,以解決細菌感染及細菌代謝相關疾病領域的未被滿足臨床需求
Listing Date2026-05-22
Listing Rules Era
Listing Rules Chapter18A生物科技
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)中國江蘇省自由貿易試驗區蘇州片區蘇州工業園區星湖街218號生物醫藥產業園B7樓701室
Business Address (Hong Kong)香港銅鑼灣勿地臣街1號時代廣場二座31樓
Place of Incorporation中國
Listing Method全球發售
Listing BoardMain Board
Websitetennortherapeutics.com
Share Registrar卓佳证券登记有限公司 (Tricor Investor Services Limited)
Registrar ContactNo data
A-Share/US Dual ListingNo
// Offering Information //
Offering Mechanism 机制B
Clawback Tiers机制B不设回拨,公开发售占比维持9.3%
Offer Period2026-05-14 to 2026-05-19
Offer PriceHK$ 75.70 / shares
Offer Price RangeFinal offer price only, no range
Lot Size50 shares
Entry ThresholdHK$ 3,785
Par ValueRMB 1.0 / shares
Global Offering Shares8,856,000
HK Public Offering Shares828,100 (9.4%)
International Placing Shares— (0.0%)
Offer Ratio~16.0%
Total Shares Post-IPO51,753,476 shares
Total Global Offering SizeHK$ 670,399,200
Public Offering SizeHK$ 62,687,170 (9.4%)
Oversubscription Multiple9,015.1x
Valid Applications275,978
Accepted Applications16,562
ReallocationNo
Greenshoe (Over-allotment Option)Yes
Final Public Offering Share9.3%
// Valuation & Financials //
Market Cap (at Offer Price)HK$ 3,917,738,133
Pre-IPO Valuation (Last Round)No data
P/E Ratio不適用(公司處於虧損狀態)
Profit/Loss Status亏损约人民币153.2百万元
Period-End Cash Balance人民币183,800,000元
Listing Expenses~HK$ 60,400,000
Listing Expenses / Funds Raised~9.64%
Total Pre-IPO Investment人民币733.4百万元
// First Day Performance
First Day CloseLoading...
// Price Chart //
Loading...
// Use of Proceeds
Use of Proceeds約71.0%用於核心產品研發及商業化;約7.0%用於TNP-2092口服製劑治療肝性腦病的IIb期MRCT;約7.3%用於其他候選產品研發;約7.2%用於建設生產工廠;約7.5%用作營運資金及一般公司用途。
// Underwriting Syndicate //
联席保荐人 (2)
中信证券(香港)有限公司 农银国际融资有限公司
保荐人兼整体协调人 (1)
中信里昂证券有限公司
整体协调人 (2)
中信里昂证券有限公司 农银国际融资有限公司
联席全球协调人 (2)
中信里昂证券有限公司 农银国际融资有限公司
联席账簿管理人 (3)
中信里昂证券有限公司 农银国际融资有限公司 华兴证券(香港)有限公司
联席牵头经办人 (5)
中信里昂证券有限公司 农银国际证券有限公司 华兴证券(香港)有限公司 富途证券国际(香港)有限公司 老虎证券(香港)环球有限公司
资本市场中介人 (6)
中信里昂证券有限公司 农银国际融资有限公司 农银国际证券有限公司 华兴证券(香港)有限公司 富途证券国际(香港)有限公司 老虎证券(香港)环球有限公司
// Service Providers //
RoleInstitution
本公司法律顾问 美迈斯律师事务所
锦天城律师事务所
竞天公诚律师事务所
保荐人/包销商法律顾问 高伟绅律师行
竞天公诚律师事务所
核数师兼申报会计师 罗兵咸永道会计师事务所
行业顾问 弗若斯特沙利文(北京)咨询有限公司上海分公司
合规顾问 迈时资本有限公司
收款银行 招商永隆银行有限公司
中信银行(国际)有限公司
// Cornerstone Investors // Allotment Results Announcement
#Investor NameShares Subscribed% of Offer Shares% of Total SharesLock-up PeriodEst. Unlock Date
1 Cumbre 6,153,028 11.76% 2027-05-21 2027-05-21
2 WuXiFund 2,848,109 5.44% 2027-05-21 2027-05-21
3 焯俊 2,450,497 4.68% 2027-05-21 2027-05-21
4 原點創投 2,203,545 4.21% 2027-05-21 2027-05-21
5 AMR美國 1,520,000 2.90% 2026-11-21 2026-11-21
6 BigBend77 1,466,857 2.80% 2027-05-21 2027-05-21
7 貝森丹康 1,436,554 2.75% 2027-05-21 2027-05-21
8 農銀二號 1,373,641 2.63% 2027-05-21 2027-05-21
9 海南世紀星河 1,351,186 2.58% 2027-05-21 2027-05-21
10 遠京投資 1,079,386 2.06% 2027-05-21 2027-05-21
11 中山西灣產業發展 863,510 1.65% 2027-05-21 2027-05-21
12 康諾 863,509 1.65% 2027-05-21 2027-05-21
13 MALInvestment 773,134 1.48% 2027-05-21 2027-05-21
14 ChaoInterests 773,134 1.48% 2027-05-21 2027-05-21
15 蘇州高特佳 723,385 1.38% 2027-05-21 2027-05-21
16 Garcia–Bugge’ 669,475 1.28% 2027-05-21 2027-05-21
17 中山創業基金 647,634 1.24% 2027-05-21 2027-05-21
18 中山翠亨 647,632 1.24% 2027-05-21 2027-05-21
19 華圓 620,850 1.19% 2026-11-21 2026-11-21
20 寧波象商 600,527 1.15% 2027-05-21 2027-05-21
21 煙台高特佳 600,527 1.15% 2027-05-21 2027-05-21
22 湖州中諾 600,527 1.15% 2027-05-21 2027-05-21
23 WilliamJ.Rieflin先生 544,150 1.04% 2027-05-21 2027-05-21
24 AMR Action Fund, 527,600 5.96% 1.01%
25 AMR盧森堡 527,600 1.01% 2026-11-21 2026-11-21
26 蘇州誠河 477,668 0.91% 2027-05-21 2027-05-21
27 乾融贏潤 457,881 0.88% 2027-05-21 2027-05-21
28 無錫國聯 450,395 0.86% 2027-05-21 2027-05-21
29 寧波姚商 450,395 0.86% 2027-05-21 2027-05-21
30 寧波燕園 450,395 0.86% 2027-05-21 2027-05-21
31 BigBend72 448,108 0.86% 2027-05-21 2027-05-21
32 遠康鼎祥 366,305 0.70% 2027-05-21 2027-05-21
33 RelativityHealthcare 352,472 0.67% 2027-05-21 2027-05-21
34 揚州錦業 327,445 0.63% 2027-05-21 2027-05-21
35 東方資產管理(香 310,500 3.51% 0.59%
36 東方資產管理 310,500 0.59% 2026-11-21 2026-11-21
37 寧波勃榮 300,263 0.57% 2027-05-21 2027-05-21
38 中山西灣投資 215,877 0.41% 2027-05-21 2027-05-21
39 博潤明都 215,877 0.41% 2027-05-21 2027-05-21
40 FrancesMcGaryMcKnight 170,699 0.33% 2027-05-21 2027-05-21
41 GraceGillespieMcKnight 170,699 0.33% 2027-05-21 2027-05-21
42 JohnStevensMcKnight先 170,699 0.33% 2027-05-21 2027-05-21
43 NellLanierMcKnight女士 170,699 0.33% 2027-05-21 2027-05-21
44 蘇穗投資 151,114 0.29% 2027-05-21 2027-05-21
45 寧波榮舜 140,319 0.27% 2027-05-21 2027-05-21
46 BigBend73 117,357 0.22% 2027-05-21 2027-05-21
47 駿昇環球有限公司 103,500 1.17% 0.20%
48 駿昇 103,500 0.20% 2026-11-21 2026-11-21
49 StevenLanierMcKnight先 77,313 0.15% 2027-05-21 2027-05-21
50 王曉東先生 77,313 0.15% 2027-05-21 2027-05-21
51 中信證券國際資本管理有 6,000 0.07% 0.01%
52 北京京國創 2,159 2027-05-21 2027-05-21
// Directors & Management //
Chairman馬振坤
Company Secretary陳榮平、叶嘉紅
執行董事 (1)
#NameEnglish NameType
1 马振坤 執行董事
非執行董事 (2)
#NameEnglish NameType
1 宋高广 非執行董事
2 Michael James Bakes 非執行董事
獨立非執行董事 (3)
#NameEnglish NameType
1 李维刚 獨立非執行董事
2 倪琳 獨立非執行董事
3 李乐平 獨立非執行董事
// Major Shareholders //
Major Shareholders & HoldingsCumbre實體為單一最大股東集團,緊隨全球發售完成後持有約15.82%權益;馬博士持有約11.41%權益;AMR Action Fund實體合計持有約10.00%權益;WuXi Fund持有約5.50%權益;原點創投持有約4.26%權益。
// Allotment Benchmarks //
Pool A (Small Subscriptions)
Shares AppliedApplicantsAllotteesExpected Lots
50 59,975 480 0.01
100 32,644 345 0.01
150 7,563 95 0.01
200 5,301 74 0.01
250 5,813 89 0.02
300 3,762 62 0.02
350 3,033 54 0.02
400 2,994 56 0.02
450 1,909 37 0.02
500 7,162 145 0.02
600 12,883 280 0.02
700 2,272 53 0.02
800 2,246 55 0.02
900 1,739 45 0.03
1,000 10,590 283 0.03
1,500 5,044 159 0.03
2,000 3,613 128 0.04
2,500 3,632 140 0.04
3,000 2,509 104 0.04
3,500 2,294 102 0.04
4,000 2,494 116 0.05
4,500 1,550 76 0.04
5,000 3,605 184 0.05
6,000 2,907 160 0.06
7,000 2,506 146 0.06
8,000 2,513 155 0.06
9,000 1,794 116 0.07
10,000 13,114 881 0.06
20,000 7,755 688 0.08
30,000 6,132 641 0.12
40,000 5,956 698 0.08
50,000 4,203 539 0.10
60,000 7,941 1,095 0.12
Pool B (Large Subscriptions)
Shares AppliedApplicantsAllotteesExpected Lots
70,000 5,706 799 0.14
80,000 4,324 660 0.16
90,000 2,652 436 0.18
100,000 11,429 2,010 0.20
200,000 5,062 1,386 0.40
300,000 2,646 938 0.60
414,050 4,711 2,052 0.83
Allotment Benchmarks
Disclaimer & Risk Warning

Site Nature: This website (cibo.qizai.ai) is an independent technology product showcase platform established by Panda Securities Limited (CE Number: BNC380). This website itself and all content displayed herein do not constitute and are not involved in any regulated activity or licensed service.

Not Investment Advice: The data on this page is automatically extracted from prospectus PDFs by AI and may contain omissions or errors. Some data is supplemented from HKEX New Listing Reports ([HKEX]). All information and data on this page are sourced from prospectuses and related historical documents, are not real-time data, and will not be automatically updated, reflecting historical information at the time of prospectus publication. All content is provided solely for AI tool analysis learning exchange and technical reference purposes, and absolutely does not constitute any investment advice, offer to buy or sell, solicitation, recommendation, or guarantee. The output of this AI analysis tool should not be interpreted as investment opinion.

Decision Responsibility: Users should make investment decisions based on their own independent judgment and consult independent licensed financial advisors when needed. Neither the Company nor this AI analysis tool shall bear any responsibility for any investment decisions made by users based on the information on this page.

Separation from Panda Securities Official Website: The content of this website is strictly distinct from the SFC-regulated licensed services provided by Panda Securities' official website (fafa.hk). No securities trading or account opening or other regulated operations can be conducted through this website.

Panda Securities Limited is a licensed corporation regulated by the Hong Kong SFC (CE Number: BNC380) and a Hong Kong Exchange Participant (Participant ID: 02229). Use of this website constitutes acceptance of this disclaimer.

Cibo — IPO & Market Data Analytics